Antimicrobial resistance (AMR)
Antimicrobial resistance (AMR) presents a growing challenge in Ethiopia, where a high burden of infectious diseases coincides with limited diagnostic and treatment resources. Multidrug-resistant bacteria are frequently identified in hospitals, complicating patient care and diminishing the effectiveness of available antibiotics.
HITM AMR research prioritizes the identification of local resistance patterns, enhancement of microbiological diagnostics, and support for antimicrobial stewardship (AMS). Current projects investigate resistant pathogens in hospital-acquired infections, urinary tract infections, neonatal sepsis, and environmental reservoirs, employing a One Health approach.
In collaboration with regional and international partners, HITM is introducing advanced diagnostic tools, including genetic resistance testing and next-generation sequencing (NGS). These technologies, combined with improved culture-based diagnostics and digital reporting systems, support clinicians in making more informed treatment decisions.
By enhancing laboratory capacity, training healthcare professionals, and advancing innovative diagnostic methods, HITM contributes to improved management of resistant infections and supports the development of long-term AMR control strategies in Ethiopia.